Home » Topics » BioWorld Science

BioWorld Science
RSS

Iterum Therapeutics initiates phase III testing of sulopenem etzadroxil

Aug. 13, 2018

First patients imaged in phase II expanded access study of 68Ga-PSMA-11

Aug. 13, 2018

Samsung Bioepis to soon begin phase I study of SB-26

Aug. 13, 2018

FDA approves The Population Council's 1-year contraceptive Annovera

Aug. 13, 2018

PARP inhibitors may be ALS drugs

Aug. 13, 2018

Researchers identify novel candidate genes involved in cognitive function

Aug. 13, 2018

Progranulin as a novel therapeutic target for the treatment of frontotemporal dementia

Aug. 13, 2018

Controlling HIV's reservoir

Aug. 13, 2018

TRK fusions actionable in blood cancers

Aug. 13, 2018

Preventing fat uptake by lymphatic system could be antiobesity approach

Aug. 13, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 1, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...